Techno Trends
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
Antengene Introduces Breakthrough ATG-022 for the treatment of Gastric Cancer
Antengene has introduced ATG-022, a first-in-class CLDN18.2-targeting antibody-drug conjugate (ADC), as an investigational therapy to receive Breakthrough Therapy designation from China’s National Medical Products Administration (NMPA) for the treatment
China Approves New Regulatory Framework for Clinical Trials
China introduces a new regulatory framework to streamline clinical trial processes for pharmaceutical companies.
Singapore Launches New Initiative to Boost Biopharmaceutical Innovation
Singapore government announces a new initiative aimed at enhancing biopharmaceutical innovation in the region.
China Strengthens Regulations on Biotech Drug Approvals to Enhance Market Access
The Chinese government has implemented new regulations aimed at speeding up the approval process for biotech drugs, promoting innovation and market access.
India Scrutinizes Biologics and Biosimilars with New Evaluation Guidelines
India has released new evaluation guidelines to enhance the integrity and quality of biologics and biosimilars approved for the market.
China Implements New Regulatory Framework for Biopharmaceutical Innovation
China has announced a comprehensive overhaul of its regulatory policies aimed at fostering innovation in the biopharmaceutical sector.
Japan Introduces New Regulatory Framework for Biosimilars to Expedite Market Entry
The Japanese government has launched a new regulatory framework aimed at streamlining the approval process for biosimilars.
AstraZeneca and Roche Announce Strategic Partnership to Advance Oncology Research in Asia
The collaboration aims to enhance oncology research and drug development across Asia.
Avidity Biosciences Introduces Breakthrough Del-zota for the Treatment of Duchenne Muscular Dystrophy
Avidity Biosciences has introduced delpacibart zotadirsen (del-zota) as the first and only investigational therapy to receive FDA Breakthrough Therapy designation for the treatment of Duchenne muscular dystrophy.
Revolution Medicines Introduces Breakthrough Elironrasib for the Treatment of KRAS G12C-Mutated Non-Small Cell Lung Cancer
Revolution Medicines has introduced elironrasib as the first and only investigational therapy to receive FDA Breakthrough Therapy designation for the treatment of adult patients with KRAS G12C-mutated
